Table 1.

Duration and distribution of subsequent treatments considered

Subsequent treatments	Second line		Third line
	Distribution of treatments (%)	Duration of treatments (months)	Distribution of treatments (%)	Duration of treatments (months)
Endocrine therapy	31.35	4.9	11.31	4.9
Targeted therapy	16.15	4.9	5.57	4.9
Chemotherapy	47.50	3.7	50.63	3.1
No active treatment	5.00	–	32.50	–
Total	100	–	100	–